Sponsored by

Keryx shares jump on successful trial results from iron deficiency drug

Shares in the Boston biotech were up 16 percent as of 11:30 a.m. after reporting results of a late-stage trial that could allow it to market it's drug to many more patients than it's current approval allows.

WSJ story features local cancer drug as a success when used off-label

​A feature story in today’s Wall Street Journal drives home the point that cancer drugs are frequently used with success in cancers for which they are not approved.

Mayo Clinic's New England lab to shut down, cut over 100 employees

The clinic said it does not see a long-term future for a facility that wasn't near a Mayo Clinic practice, and that its landlord had requested the company enter into a long-term lease.

​Affymetrix done waffling, says it wants to be bought by Thermo after all

The California diagnostics maker has reiterated its recommendation to its shareholders to vote in favor of the merger with Thermo Fisher for $1.3 billion.

Bloomberg, others give $125M to Johns Hopkins for new cancer research center

FDA approves 2 Lannett products